Clinical Trials
3 trialsNCT00071071 2023-05-18
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
Genmab
Phase 2 Completed
NCT00071084 2023-04-28
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
Genmab
Phase 2 Completed
NCT00127881 2012-07-26
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Emergent Product Development Seattle LLC
Phase 3 Terminated